Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-043069
Filing Date
2013-08-06
Accepted
2013-08-06 17:06:31
Documents
1
Period of Report
2013-07-29

Document Format Files

Seq Description Document Type Size
1 ROCHE FORM 3 rrd387256.html 3  
1 ROCHE FORM 3 rrd387256.xml 3 2101
  Complete submission text file 0001181431-13-043069.txt   3736
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 41 MOORES ROAD FRAZER PA 19355
Business Address
ROCHE ROBERT P JR (Reporting) CIK: 0001210193 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32302 | Film No.: 131014334